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ackground to the debate: In many countries, the number 
of patients waiting for a kidney transplant is increasing. 
But there is a widespread and serious shortage of kidneys 
for transplantation, a shortage that can lead to suffering and 
death. One approach to tackling the shortage is for a patient 
with renal disease to buy a kidney from a living donor, who 
is often in a developing country, a sale that could—in theory 
at least—help to lift the donor out of poverty. Such kidney 
sales are almost universally illegal. Proponents of kidney 
sales argue that since the practice is widespread, it would 
be safer to formally regulate it, and that society should 
respect people’s autonomous control over their bodies. 
Critics express concern about the potential for exploitation 
and coercion of the poor, and about the psychological and 
physical after-effects on the donors of this illegal kidney 
trade.
    Tarif Bakdash’s Viewpoint: Poor People Should 
Have the Right to Exercise Their Autonomy by 
Selling Their Organs
    What would you do if you had to choose between selling 
your kidney and letting your children starve? I have come to 
believe that selling one’s own kidney would be better than 
enduring the horrors of poverty. Living below the poverty line 
on less than a dollar per day makes it hard for parents to feed 
their children, let alone to clothe them, and organ sales offer 
a way out of destitution.
    After returning to Syria from the United States, I learned 
about a man who had sold one of his kidneys to help lift his 
family out of poverty and pay for his children’s education. 
The Arabic news Web site Al-Arabiya (http:⁄⁄www.alarabiya.
net) told the story of a young man living in the United 
Arab Emirates who wanted to sell his kidney in order to 
help his family of two wives and six children living at their 
grandparent’s home.   The Tribune, India   reported that a 42-
year-old Nepalese man named Man Dhoj Tamang sold one of 
his kidneys to pay off his debts and buy a piece of land [1].
    Having trained and taught in North America for almost 14 
years, my initial reaction to these reports was that such organ 
sales were immoral. I was aware that many medical societies 
and health-care organizations took the position that selling 
organs is unethical. For example, the Ethics Committee of 
the Transplantation Society advises transplant surgeons that: 
“No transplant surgeon/team shall be involved directly or 
indirectly in the buying or selling of organs/tissues or in 
any transplant activity aimed at commercial gain to himself/
herself or an associated hospital or institute” [2]. The 
World Health Organization and the International Congress 
on Transplantation in Developing Countries have also 
condemned the selling of organs, arguing that it is a coercive 
practice that exploits the poor [3–5]. 
    But then I remembered my own experience of poverty, 
standing in long lines to buy a few oranges or a little bread, 
having to live without electricity and running water, and 
sleeping on the ﬂ  oor with roaches crawling over my face. And 
then it struck me that   poverty itself   is a kind of coercion. None 
of the decisions that any poor person makes are made on the 
basis of free will—instead, these decisions are all dependent 
on the person’s dire ﬁ  nancial situation. 
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    We live in a world of startling inequities: of the 10.8 
million children under age ﬁ  ve who die each year, 10 
million (more than 92 percent) live in the lower-income 
countries [6]. Millions of the world’s poorest people have 
no access to clean water, and no opportunities to educate 
themselves or their children. It is no wonder that some of 
these people sell their organs to have a glimpse of a better 
life. The argument that we should protect the poor from 
being exploited by banning them from selling their organs 
is a myth. The poor are always exploited from the day they 
are born, and in all avenues of life. The only thing of value 
left for some of them is their bodies. 
    It is surely a kind of hypocrisy and arrogance on the part of 
the rich world to reject the right of poor people to exercise 
their autonomy when it comes to selling their organs. Is it 
ethically justiﬁ  able to deprive the world’s poorest people of 
the chance for a better life? The decision to sell one’s organs 
is never taken lightly—it is often an act of great altruism 
driven by the desire to create a better life for one’s family. 
    Abdallah Daar, Director of the Program in Applied 
Ethics and Biotechnology at the University of Toronto, has 
argued that the position taken by the Ethics Committee 
of the Transplantation Society “has been totally useless in 
stopping the increase of the buying and selling of organs” 
[7]. Unfortunately, those who currently sell their organs risk 
major complications because the surgery is often done under 
sub-standard conditions. It would be good medical practice 
for the buying and selling of organs to be taken out of the 
black market and become regulated. Instead of banning 
organ sales, I would add my voice to the growing number 
of commentators that argue that the sale of organs should 
be legalized and regulated [8–10]. Janet Radcliffe-Richards 
and colleagues have argued that “all the evidence we have 
shows that there is much more scope for exploitation and 
abuse when a supply of desperately wanted goods is made 
illegal” [10]. And the best way, they say, to avoid coercion and 
exploitation of the poor in organ sales would be to ensure 
“regulation and perhaps a central purchasing system, to 
provide screening, counselling, reliable payment, insurance, 
and ﬁ  nancial advice.”
    Of course we must address the underlying root causes of 
poverty, so that people are never forced to have to sell their 
bodily organs. But until we solve the problems of social, 
political, educational, and economical underdevelopment we 
need to face reality by legalizing and regulating organ sales in 
the developing world.
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    Nancy Scheper-Hughes’ Viewpoint: Dividing the 
World into Organ Buyers and Sellers Is a Medical, 
Social, and Moral Tragedy 
    The late Michael Friedlaender, a transplant nephrologist 
at Hadassah Hospital in Jerusalem, was initially “adamant that 
organ trading was wrong and would lead to terrible crimes” 
[11], but he later changed his position. He described how 
300 of his patients, Jews and Arabs, traveled abroad for illegal 
kidney transplants from paid living donors. Although a few of 
these patients fell seriously ill and one died as a result of their 
illicit “black market” transplant, most fared as well or better 
than those transplanted safely at home with a cadaver kidney. 
Friedlaender joined several respected medical colleagues and 
prominent bioethicists in supporting proposed legislation in 
Israel to govern regulated kidney sales [12]. Their refusal to 
condemn the kidney trade helped pave the way for a global 
kidney trade that harmed as well as healed people and that 
engendered new antagonisms toward Israel as a global leader 
in “transplant tourism.” In August 2006, the Jerusalem district 
court instructed HMOs to pay kidney donors US$14,000 to 
cover their expenses, essentially legalizing sales [13]. The 
philosopher Janet Radcliffe-Richards and her colleagues also 
called for a regulated market in organ sales: “If a living donor 
can do without an organ,” they said, “why shouldn’t the 
donor proﬁ  t and medical science beneﬁ  t?” [10].
    When it comes to organ sales, the ethical conﬂ  ict between 
the principles of non-malfeasance (“do no harm”) and 
beneﬁ  cence (the moral duty to perform good acts) is being 
resolved via the market principle: those able to broker or 
buy a human organ should be allowed to do so. Paying 
for a kidney “donation” is often described as a “win–win” 
situation beneﬁ  cial to both parties [10]. Patient autonomy 
has become the ﬁ  nal arbiter of medical values. Social justice 
and notions of the good society hardly ﬁ  gure in these 
discussions. Virtue in suffering and grace in dying can only 
appear as patently absurd. 
    But the transformation of a person into a “life” that must 
be prolonged or saved at any cost has turned human life into 
the ultimate commodity fetish. The absolute value of a single 
human life saved or prolonged   at any cost   ends all ethical 
inquiry and erases any possibility of a global social ethic. 
Meanwhile, the trafﬁ  c in kidneys reduces the human content 
of all the lives it touches.
    The arguments for “regulation” as opposed to prohibition 
have some merit, but are out of touch with the social and 
medical realities in many developing countries. Often 
institutions in these countries created to “monitor” organ 
harvesting and distribution are weak, dysfunctional, corrupt, 
or compromised by the impunity of the organ brokers, and by 
outlaw surgeons willing to violate the ﬁ  rst premise of classical 
medical bioethics: above all, do no harm. 
    The results of the few available studies of the effects of 
nephrectomy on kidney sellers in India [14] and Iran [15,16] 
are clear. Even under attempts (as in Iran) to regulate and 
control systems of “compensated gifting” by the Ministry of 
Health, the outcomes are troubling. Paid donors are not 
followed and some who encounter subsequent medical 
problems are turned away. Our research among hundreds of 
kidney sellers in Moldova, Romania, Turkey, the Philippines, 
and Brazil has shown that many suffer post-operatively from 
chronic pain, social isolation, stigma, and severe psychological 
problems [17]. Their economic conditions decline following 
the sale due to negative perceptions and self-perceptions 
of kidney sellers as weak and disabled individuals. The 
feelings of disappointment, anger, resentment, and even 
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seething hatred by kidney sellers toward the surgeons and the 
recipients of their organs suggest that the practice engenders 
deep social pathologies. These outcomes have been found 
in countries where kidney selling is illegal as well as in Iran, 
where kidney selling is legal and regulated.
    Organs Watch, an independent, university-based human 
rights and research project, has provided assistance to kidney 
sellers in Moldova, Brazil, and the Philippines, including 
diagnostic exams and sonograms. These revealed that many 
organ sellers face a range of post-operative complications 
and medical problems, including hypertension and kidney 
insufﬁ  ciency, without access to adequate medical care 
or medications (http:⁄⁄sunsite.berkeley.edu/biotech/
organswatch/pages/research.html). Kidney sellers ﬁ  nd 
themselves unemployable because they are unable to sustain 
the demands of heavy agricultural or construction work, 
the only labor available to men with their skills. Kidney 
sellers are often alienated from their families and coworkers, 
excommunicated from their churches, and excluded from 
marriage. The children and spouses of kidney sellers are 
subject to cruel taunts (“Your father is a one-kidney!”) and 
ridicule. 
    In our studies, male kidney sellers suffered from exclusion 
by potential employers and coworkers, and by girlfriends and 
wives who labeled them as “weak,” “inadequate,” or mutilated. 
“No young woman in the village will marry a man with the 
tell-tale scar of a kidney seller,” a village elder in Mingir, 
Moldova, told me. Even in the United States, kidney donors 
have died or become comatose as a result of donation [18]. 
In the context of for-proﬁ  t transplant tourism, nephrectomy 
is a risky procedure [19].
    Bioethical arguments supporting the right to sell an 
organ are based on Euro-American notions of contract and 
individual “choice.” But the social and economic contexts 
make the “choice” to sell a kidney in an urban slum of 
Calcutta, or in a Brazilian   favela   or Philippine shantytown, 
anything but a “free” and “autonomous” one. Consent is 
problematic with “the executioner”—whether on death 
row or at the door of the slum resident—looking over one’s 
shoulder. Putting a market price on body parts—even a 
fair one—exploits the desperation of the poor, turning 
their suffering into a medical opportunity. Asking the 
law to negotiate a fair price for a live human kidney goes 
against everything that contract theory stands for. When 
concepts such as individual agency and autonomy are 
invoked in defending the “right” to sell an organ, medical 
anthropologists suggest that certain “living” things are not 
alienable or proper candidates for commodiﬁ  cation. 
    The problems multiply when the buyers and sellers 
are unrelated. In this situation, the sellers are likely 
to be extremely poor and trapped in life-threatening 
environments facing everyday risks to their survival, 
including exposure to urban violence, transportation- and 
work-related accidents, and infectious diseases that could 
compromise their single kidney. And when that ultimate 
“spare part” fails, kidney sellers often have no access to 
dialysis, let alone to organ transplantation. Moldova, which 
inadvertently supplied a great many desperate kidney sellers 
to afﬂ  uent transplant tourists in Turkey, South Africa, and 
the United States, is today one of Europe’s poorest nations. 
The country has only one public transplant unit and no 
capacity to guarantee dialysis to all those who may require it, 
least of all to rural men who fall into the hands of ruthless 
international kidney brokers. 
    Wouldn’t a regulated system be better than the current 
state of racketeering in human kidneys? Perhaps, but how 
can a national government set a price on a healthy, but 
destitute, human being’s body part without compromising 
essential democratic and ethical principles that guarantee 
the equal value of all human lives? Any national regulatory 
system would have to compete with global black markets that 
establish the value of human organs based on consumer-
oriented prejudices. In today’s kidney market, Asian kidneys 
are “worth less” than Middle Eastern kidneys and American 
kidneys worth more than European ones. The circulation 
of kidneys transcends national borders, and international 
markets will coexist and compete aggressively with any 
national, regulated systems. Surgeons whose primary 
responsibility is to provide care should not be advocates of 
paid self-mutilation by anonymous strangers even in the 
interest of saving lives.
    Ethical solutions to the chronic scarcity of human 
organs are not always palatable to the public, but must be 
considered. Foremost among these are systems of educated, 
informed “presumed consent,” in which   all   citizens are 
assumed to be organ donors at brain death unless they have 
ofﬁ  cially stipulated their refusal beforehand. This practice, 
which is widespread in parts of Europe, preserves the value 
of organ transplantation as a social good in which no one is 
included or excluded on the basis of their ability to pay. 
    While many individuals have beneﬁ  ted from the ability 
to get the organs they need through illegal circuits, the 
violence associated with kidney selling gives reason to pause. 
The division of the world into organ buyers and sellers is a 
medical, social, and moral tragedy of immense and not yet 
fully recognized proportions.  
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